Shubham Sharma
Shubham Sharma has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Sri Harsha Kota
Department of Civil Engineering, Indian Institute of Technology Delhi, New Delhi, India
4 shared publications - Mina Chandra
Department of Psychiatry, Centre of Excellence in Mental Health, Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital, New Delhi, India
2 shared publications Anshika
1 shared publicationHao Guo
Department of Civil and Environmental Engineering, Louisiana State University, Baton Rouge LA, 70803, USA
1 shared publicationHongliang Zhang
Department of Environmental Science and Engineering, Fudan University, Shanghai, China
1 shared publication- Hongliang Zhang
Fudan University (Shanghai, China)
1 shared publication
Latest Publications
- Open Access
- 15 August 2026
- Published by Elsevier in Environment International
- Vol. 215, 110464
Short-term exposure to PM2.5 and its components and neuropsychiatric hospitalizations in Delhi, India
- 15 August 2026
- Published by Elsevier in Environment International
- Vol. 215, 110464
Open AccessShort-term exposure to PM2.5 and its components and neuropsychiatric hospitalizations in Delhi, India
- 4 June 2024
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (6) , 1914-1934
Mechanistic Insights into Cellular and Molecular Targets of Zinc Oxide Quantum Dots (ZnO QDs) in Fungal Pathogen, Candida albicans: One Drug Multi-Targeted Therapeutic Approach
Rationally designed multitargeted drugs, known as network therapeutics/multimodal drugs, have emerged as versatile therapeutic solutions to combat drug-resistant microbes. Here, we report novel mechanistic insights into cellular and molecular targets of ZnO quantum dots (QDs) against Candida albicans, a representative of fungal pathogens. Stable, monodispersed 4-6 nm ZnO QDs were synthesized using a wet chemical route, which exhibited dose-dependent inhibition on the growth dynamics of Candida. Treatment with 200 μg/mL ZnO QDs revealed an aberrant morphology and a disrupted cellular ultrastructure in electron microscopy and led to a 23% reduction in ergosterol content and a 53% increase in intracellular reactive oxygen species. Significant increase in steady-state fluorescence polarization and fluorescence lifetime decay of membrane probe 1,6-diphenyl-1,3,5-hexatriene (DPH) in treated cells, respectively, implied reduction in membrane fluidity and enhanced microviscosity. The observed reduction in passive diffusion of fluorescent Rhodamine 6G across the membrane validated the intricate relationship between ergosterol, membrane fluidity, and microviscosity. An inverse relationship existing between ergosterol biosynthetic genes, ERG11 and ERG3 in treated cells, related well with displayed higher susceptibilities. Furthermore, treated cells exhibited impaired functionality and downregulation of ABC drug efflux pumps. Multiple cellular targets of ZnO QDs in Candida were validated by in silico molecular docking. Thus, targeting ERG11, ERG3, and ABC drug efflux pumps might emerge as a versatile, nano-ZnO-based strategy in fungal therapeutics to address the challenges of drug resistance.
- 4 June 2024
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (6) , 1914-1934
Mechanistic Insights into Cellular and Molecular Targets of Zinc Oxide Quantum Dots (ZnO QDs) in Fungal Pathogen, Candida albicans: One Drug Multi-Targeted Therapeutic Approach
Rationally designed multitargeted drugs, known as network therapeutics/multimodal drugs, have emerged as versatile therapeutic solutions to combat drug-resistant microbes. Here, we report novel mechanistic insights into cellular and molecular targets of ZnO quantum dots (QDs) against Candida albicans, a representative of fungal pathogens. Stable, monodispersed 4-6 nm ZnO QDs were synthesized using a wet chemical route, which exhibited dose-dependent inhibition on the growth dynamics of Candida. Treatment with 200 μg/mL ZnO QDs revealed an aberrant morphology and a disrupted cellular ultrastructure in electron microscopy and led to a 23% reduction in ergosterol content and a 53% increase in intracellular reactive oxygen species. Significant increase in steady-state fluorescence polarization and fluorescence lifetime decay of membrane probe 1,6-diphenyl-1,3,5-hexatriene (DPH) in treated cells, respectively, implied reduction in membrane fluidity and enhanced microviscosity. The observed reduction in passive diffusion of fluorescent Rhodamine 6G across the membrane validated the intricate relationship between ergosterol, membrane fluidity, and microviscosity. An inverse relationship existing between ergosterol biosynthetic genes, ERG11 and ERG3 in treated cells, related well with displayed higher susceptibilities. Furthermore, treated cells exhibited impaired functionality and downregulation of ABC drug efflux pumps. Multiple cellular targets of ZnO QDs in Candida were validated by in silico molecular docking. Thus, targeting ERG11, ERG3, and ABC drug efflux pumps might emerge as a versatile, nano-ZnO-based strategy in fungal therapeutics to address the challenges of drug resistance.
- 1 September 2020
- Published by Elsevier in Chemosphere
- Vol. 255, 126969
Estimating ground level PM2.5 concentrations and associated health risk in India using satellite based AOD and WRF predicted meteorological parameters
- 1 September 2020
- Published by Elsevier in Chemosphere
- Vol. 255, 126969
Estimating ground level PM2.5 concentrations and associated health risk in India using satellite based AOD and WRF predicted meteorological parameters
- Top Cited Papers
- 1 August 2020
- Published by Elsevier in Science of The Total Environment
- Vol. 728, 138878
Effect of restricted emissions during COVID-19 on air quality in India
- 1 August 2020
- Published by Elsevier in Science of The Total Environment
- Vol. 728, 138878
Top Cited PapersEffect of restricted emissions during COVID-19 on air quality in India
- 17 July 2020
- Published by Springer Nature in Current Pollution Reports
- Vol. 6 (4) , 345-367
Health Effects Associated with PM2.5: a Systematic Review
- 17 July 2020
- Published by Springer Nature in Current Pollution Reports
- Vol. 6 (4) , 345-367
Health Effects Associated with PM2.5: a Systematic Review